AstraZeneca’s COVID-19 vaccine; Type 1 diabetes research updates; FDA nod to Zebra’s X-ray modelling AI; UniQure/CSL haemophilia B gene therapy curbs bleeding in phase 3
Delveinsight
DECEMBER 10, 2020
In a pooled analysis of 11,636 participants enrolled in two separate clinical trials in the U.K. trial came to give some subjects a half-dose primer and offers potential explanations for the effect but omits the key question of whether the regimen has 90% efficacy or not. The Lancet paper offers background on how the U.K.
52 
Let's personalize your content